Study of Motavizumab (MEDI-524) and Palivizumab in the Same Respiratory Syncytial Virus (RSV) Season

This study has been completed.

Study NCT00316264 Information provided by MedImmune LLC

First Received: April 18, 2006 Last Updated: July 17, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2007
Estimated Primary Completion Date:	No date given